Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 20-F, Date: 2010-04-16
Original SEC Filing: Click here

---

Webplus: SVA/20100416/20-F/1/000.htm SEC Original: a10-7773_220f.htm
FORM 20-F (Mark One) o OR x For the fiscal year ended December 31, 2009 OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . SINOVAC BIOTECH LTD. N/A Antigua, West Indies (Jurisdiction

---

---

Webplus: SVA/20100416/20-F/2_EX-4.14/000.htm SEC Original: a10-7773_2ex4d14.htm
Asset Acquisition Agreement In Relation to Guangda Pharmaceutical Party A: Beijing Xingchang High-tech Development Corporation Legal Representative: Hailing Wang Address: No. 9 Chaoqian Road, Changping District Beijing Party B: Sinovac Biotech Co., Ltd. Legal Representative: Aihua Pan Address: No. 39 Shangdi West Road, Haidian District Beijing Whereas: 1. Party A is a development enterprise located in the Changping Section of

---

---

Webplus: SVA/20100416/20-F/3_EX-8.1/000.htm SEC Original: a10-7773_2ex8d1.htm
List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Beijing Sinovac Biological Technology Co., Ltd., a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company 1 EX-8.1 3 a10-7773_2ex8d1.htm EX-8.1

---

---

Webplus: SVA/20100416/20-F/4_EX-12.1/000.htm SEC Original: a10-7773_2ex12d1.htm
Certification by the Chief Executive Officer I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SVA/20100416/20-F/5_EX-12.2/000.htm SEC Original: a10-7773_2ex12d2.htm
Certification by the Chief Financial Officer I, Jinling Qin , certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: SVA/20100416/20-F/6_EX-13.1/000.htm SEC Original: a10-7773_2ex13d1.htm
CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER In connection with the Annual Report of Sinovac Biotech Ltd. Weidong Yin 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 16, 2010 1 EX-13.1 6 a10-7773_2ex13d1.htm EX-13.1

---

---

Webplus: SVA/20100416/20-F/7_EX-13.2/000.htm SEC Original: a10-7773_2ex13d2.htm
CERTIFICATION BY THE CHIEF FINANCIAL OFFICER In connection with the Annual Report of Sinovac Biotech Ltd. Jinling Qin 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 16, 2010 1 EX-13.2 7 a10-7773_2ex13d2.htm EX-13.2

---

---

Webplus: SVA/20100416/20-F/8_EX-15.1/000.htm SEC Original: a10-7773_2ex15d1.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-161827) pertaining to the 2003 Stock Option Plan of Sinovac Biotech Ltd., of our reports dated April 16, 2010, with respect to the consolidated financial statements of Sinovac Biotech Ltd., and the effectiveness of internal control over financial reporting

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 20-F, Date: 2010-04-16CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085